Chemomab Therapeutics Ltd. (CMMB) Free cash flow 2018–2025
Chemomab Therapeutics Ltd. (CMMB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.1MFY2025 · since FY2018: -$14.4M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | +27.6% |
| FY2024 | -$15.4M | +34.8% |
| FY2023 | -$23.6M | -15.5% |
| FY2022 | -$20.4M | -62.0% |
| FY2021 | -$12.6M | -138.9% |
| FY2020 | -$5.3M | +68.1% |
| FY2019 | -$16.6M | -14.7% |
| FY2018 | -$14.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice